perimenopause.com Free Assessment

We couldn't find your report on this device

Your assessment results are stored privately in the browser where you took the assessment. They never leave your device. If you're on a different device or cleared your browsing data, just retake the assessment. It takes about 3 minutes.

Take the Assessment
perimenopause.com

Perimenopause Symptom Summary

Self-reported symptom assessment · Completed

Significant symptoms

Selected as having a major impact on daily life

Your symptoms

As reported in your assessment

Mild symptoms

Present but lower impact

Pattern by category

Number of symptoms reported in each area

Your treatment options, explained

What's FDA-approved, what the evidence supports, and what's hype

Backed by strong evidence (some FDA-approved)

  • Hormone therapy: for example, transdermal estradiol (patch or gel) with micronized progesterone. FDA-approved for moderate to severe hot flashes and night sweats, and first-line for those symptoms per The Menopause Society's 2022 position statement. It isn't right for everyone. In late 2025 the FDA began removing some boxed warnings from these labels, but the labels still list risks and reasons not to use it, such as a history of breast cancer, blood clots, stroke, heart attack, or unexplained vaginal bleeding. Women with a uterus need a progestogen like progesterone to protect the uterine lining, and risks rise with age at starting.
  • Fezolinetant (Veozah): an FDA-approved non-hormonal option for moderate to severe hot flashes and night sweats, for women who can't take or don't want hormones. It carries an FDA boxed warning for serious liver injury, so it requires liver blood tests before starting and at set points over the first 9 months. Signs of liver problems, like yellowing skin or eyes or dark urine, mean stopping it and seeking care.
  • Low-dose vaginal estrogen: an FDA-approved, standard treatment for vaginal dryness and discomfort. It works mostly locally, but it isn't risk-free, and anyone with a history of breast cancer should discuss it with their oncology team.
  • CBT-I and non-hormonal prescriptions: CBT-I (a structured sleep therapy) is the first-line treatment for chronic insomnia. For some women, non-hormonal prescriptions can also help with hot flashes, sleep, or mood. Most are used off-label, and each has side effects to weigh with a clinician.

Mostly hype. Spend carefully

  • Compounded "bioidentical" pellets: unregulated dosing, not FDA-approved, and specifically cautioned against by The Menopause Society.
  • Hormone-"balancing" test panels: perimenopause is a clinical diagnosis based on age, cycle changes, and symptom pattern; single-day hormone levels swing too much to be diagnostic.
  • Untested supplement stacks: a handful of supplements have modest evidence for specific symptoms; "hormone support" blends generally don't.

Which of these fits you depends on your symptoms, history, and preferences, which is exactly what a clinician trained in perimenopause walks you through. That's the care we're building.

This summary is an educational self-assessment, not a medical diagnosis. It is intended to support, not replace, consultation with a qualified healthcare provider. Generated from answers stored privately on this device.

Online visits are coming in late 2026

We're building visits with licensed clinicians. From home, no waiting room. Be first in line.

Get first access

This website provides educational information about perimenopause and is not a substitute for professional medical advice, diagnosis, or treatment.

© 2026 Perimenopause.com. All rights reserved.